Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inf...
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases
About this item
Full title
Author / Creator
Rabinowitz, Keren , Navon, Michal , Edelman-Klapper, Hadar , Zittan, Eran , Bar-Gil Shitrit, Ariella , Goren, Idan , Avni-Biron, Irit , Ollech, Jacob , Lichtenstein, Lev , Banai-Eran, Hagar , Yanai, Henit , Snir, Yifat , Pauker, Maor , Friedenberg, Adi , Levy-Barda, Adva , Segal, Arie , Broitman, Yelena , Maoz, Eran , Ovadia, Baruch , Aharoni Golan, Maya , Shachar, Eyal , Ben-Horin, Shomron , Maharshak, Nitsan , Mor, Michal , Ben Zvi, Haim , Eliakim, Rami , Barkan, Revital , Sharar-Fischler, Tali , Goren, Sophy , Krugliak, Noy , Pichinuk, Edward , Mor, Michael , Werbner, Michal , Alter, Joel , Abu-Taha, Hanan , Kaboub, Kawsar , Dessau, Moshe , Gal-Tanamy, Meital , Cohen, Dani , Freund, Natalia , Dotan, Iris and on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Patients with inflammatory bowel disease (IBD) treated with anti-tumor-necrosis factor-alpha (TNFα) exhibited lower serologic responses one-month following the second dose of the COVID-19 BNT162b2 vaccine compared to those not treated with anti-TNFα (non-anti-TNFα) or to healthy controls (HCs). We comprehensively analyzed long-term humoral response...
Alternative Titles
Full title
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases
Authors, Artists and Contributors
Author / Creator
Navon, Michal
Edelman-Klapper, Hadar
Zittan, Eran
Bar-Gil Shitrit, Ariella
Goren, Idan
Avni-Biron, Irit
Ollech, Jacob
Lichtenstein, Lev
Banai-Eran, Hagar
Yanai, Henit
Snir, Yifat
Pauker, Maor
Friedenberg, Adi
Levy-Barda, Adva
Segal, Arie
Broitman, Yelena
Maoz, Eran
Ovadia, Baruch
Aharoni Golan, Maya
Shachar, Eyal
Ben-Horin, Shomron
Maharshak, Nitsan
Mor, Michal
Ben Zvi, Haim
Eliakim, Rami
Barkan, Revital
Sharar-Fischler, Tali
Goren, Sophy
Krugliak, Noy
Pichinuk, Edward
Mor, Michael
Werbner, Michal
Alter, Joel
Abu-Taha, Hanan
Kaboub, Kawsar
Dessau, Moshe
Gal-Tanamy, Meital
Cohen, Dani
Freund, Natalia
Dotan, Iris
on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_002599bbb4e74664a74f8cb9e8c3051d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_002599bbb4e74664a74f8cb9e8c3051d
Other Identifiers
ISSN
2076-393X
E-ISSN
2076-393X
DOI
10.3390/vaccines10081186
